About Alveo Technologies
Alveo Technologies is a company based in Alameda (United States) founded in 2014 by Mike Aicher and Lawrence M Blatt. Alveo Technologies has raised $63.61 million across 4 funding rounds from investors including Gates Foundation, Maxim Group and Supply Change Capital. Alveo Technologies offers products and services including Alveo Sense™ Poultry Avian Influenza Test and Alveo Platform. Alveo Technologies operates in a competitive market with competitors including NeuMoDx, GenMark Diagnostics, Biomeme, Sense Biodetection and Bioskryb, among others.
- Headquarter Alameda, United States
- Founders Mike Aicher, Lawrence M Blatt
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Alveo S.R.O.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$63.61 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Gates Foundation
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alveo Technologies
Alveo Technologies offers a comprehensive portfolio of products and services, including Alveo Sense™ Poultry Avian Influenza Test and Alveo Platform.
Rapid molecular tool for detecting avian influenza in poultry samples.
Handheld analyzer for on-site pathogen testing in various sectors.
People of Alveo Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of Alveo Technologies
Alveo Technologies has successfully raised a total of $63.61M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Alveo Technologies
Alveo Technologies has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation, Maxim Group and Supply Change Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Financial advisory services are provided across multiple sectors.
|
Locked | Locked | Locked | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked |
Investor details for Alveo Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alveo Technologies
Investment portfolio details for Alveo Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Alveo Technologies
Detailed financials for Alveo Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alveo Technologies Comparisons
Peer comparison for Alveo Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alveo Technologies
Alveo Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuMoDx, GenMark Diagnostics, Biomeme, Sense Biodetection and Bioskryb, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Smartphone-based DNA detection platform is developed for diagnostics.
|
|
| Locked | Locked | Locked |
Provider of point of care molecular diagnostics solutions
|
|
| Locked | Locked | Locked |
Genome amplification systems for DNA sequencing are developed.
|
Detailed competitors of Alveo Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alveo Technologies
Complete news archive for Alveo Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alveo Technologies
Alveo Technologies was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Alveo Technologies is headquartered in Alameda, United States. It is registered at Alameda, California, United States.
Alveo Technologies is a funded company, having raised a total of $63.61M across 4 funding rounds to date.
Alveo Technologies is an early-stage biotech company developing point of care molecular diagnostic devices. Alveos technology incorporates cloud-based analytics with rapid, point of care molecular testing to create an integrated, connected solution for infectious disease diagnostics.
Alveo Technologies's top competitors include GenMark Diagnostics, NeuMoDx and Bioskryb.
Alveo Technologies offers Alveo Sense™ Poultry Avian Influenza Test and Alveo Platform.
Alveo Technologies has 3 investors. Key investors include Gates Foundation, Maxim Group, and Supply Change Capital.